Nuvation Bio terminates collaboration agreement with SPARCBIO LLC effective Jan 2022

Nuvation Bio Inc.

On Oct 22, 2021, Nuvation notified SPARCBIO LLC of termination effective Jan 21, 2022 without penalty.
The collaboration agreement was originally dated Jan 21, 2019 among Nuvation, RePharmation, and SPARCBIO LLC.
Company stated it no longer requires the services under the collaboration agreement.
No additional costs, penalties, or new agreements were disclosed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.